These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17611550)

  • 1. Treatment patterns of hypertension and dyslipidaemia in hypertensive patients at higher and lower risk of cardiovascular disease in primary care in the United Kingdom.
    MacDonald TM; Morant SV; Mozaffari E
    J Hum Hypertens; 2007 Dec; 21(12):925-33. PubMed ID: 17611550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: Real-world evidence from primary care.
    Ling JZJ; Montvida O; Khunti K; Zhang AL; Xue CC; Paul SK
    Diabetes Obes Metab; 2021 Jul; 23(7):1518-1531. PubMed ID: 33651456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and treatment of hypertensive patients with multiple concomitant cardiovascular risk factors in The Netherlands and Italy.
    Sturkenboom MC; Dieleman JP; Picelli G; Mazzaglia G; Mozaffari E; Filippi A; Cricelli C; van der Lei J
    J Hum Hypertens; 2008 Oct; 22(10):704-13. PubMed ID: 18668128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk profile of young hypertensive patients: the OPENJOVEN study.
    Martell-Claros N; Galgo-Nafria A;
    Eur J Prev Cardiol; 2012 Jun; 19(3):534-40. PubMed ID: 21474438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in Southwestern Ontario, Canada.
    Petrella RJ; Merikle E
    Clin Ther; 2008 Jun; 30(6):1145-54. PubMed ID: 18640470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pravastatin for cardiovascular event primary prevention in patients with mild-to-moderate hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
    Kushiro T; Mizuno K; Nakaya N; Ohashi Y; Tajima N; Teramoto T; Uchiyama S; Nakamura H;
    Hypertension; 2009 Feb; 53(2):135-41. PubMed ID: 19104004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010.
    Tuppin P; Ricci-Renaud P; de Peretti C; Fagot-Campagna A; Gastaldi-Menager C; Danchin N; Alla F; Allemand H
    Arch Cardiovasc Dis; 2013 May; 106(5):274-86. PubMed ID: 23769402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk in women attending primary care centres: baseline data of the EVA study.
    Fernández-Vega F; Prieto-Diaz MÁ; Redondo M; García-Norro FJ; Suliman N; Díaz A; Vidal C; Rodríguez JM; Montero FJ; González MB; Suarez S; García JJ; Redondo P
    Nephrol Dial Transplant; 2012 Dec; 27 Suppl 4():iv22-7. PubMed ID: 23258806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
    Scholze J; Lilienthal W; Bramlage P
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():103-10. PubMed ID: 17955787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular mortality in hypertensive men according to presence of associated risk factors.
    Thomas F; Rudnichi A; Bacri AM; Bean K; Guize L; Benetos A
    Hypertension; 2001 May; 37(5):1256-61. PubMed ID: 11358937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missed opportunities for the prevention of cardiovascular disease among British hypertensives in primary care.
    Foss FA; Dickinson E; Hills M; Thomson A; Wilson V; Ebrahim S
    Br J Gen Pract; 1996 Oct; 46(411):571-5. PubMed ID: 8945793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insomnia symptoms and subsequent cardiovascular medication: a register-linked follow-up study among middle-aged employees.
    Haaramo P; Rahkonen O; Hublin C; Laatikainen T; Lahelma E; Lallukka T
    J Sleep Res; 2014 Jun; 23(3):281-9. PubMed ID: 24313664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Mazzaglia G; Ambrosioni E; Alacqua M; Filippi A; Sessa E; Immordino V; Borghi C; Brignoli O; Caputi AP; Cricelli C; Mantovani LG
    Circulation; 2009 Oct; 120(16):1598-605. PubMed ID: 19805653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidaemia in the elderly: to treat or not to treat?
    Katsiki N; Kolovou G; Perez-Martinez P; Mikhailidis DP
    Expert Rev Clin Pharmacol; 2018 Mar; 11(3):259-278. PubMed ID: 29303009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.
    Rodrigues CJ; Ribeiro HF; Ribeiro AB; Zanella MT; Batista MC
    Metab Syndr Relat Disord; 2012 Jun; 10(3):195-201. PubMed ID: 22313142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK.
    McElduff P; Lyratzopoulos G; Edwards R; Heller RF; Shekelle P; Roland M
    Qual Saf Health Care; 2004 Jun; 13(3):191-7. PubMed ID: 15175489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of 5413 hypertensive patients: a cross-sectional study.
    Paulsen MS; Sondergaard J; Reuther L; Larsen PS; Munck AP; Larsen PV; Damsgaard J; Poulsen L; Hansen DG; Jacobsen IA; Larsen ML; Christensen HR; Christensen B; Andersen M
    Fam Pract; 2011 Dec; 28(6):599-607. PubMed ID: 21596691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.